{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:03:22Z","timestamp":1791864202937,"version":"4.3.4"},"reference-count":70,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T00:00:00Z","timestamp":1647734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Severe ocular allergic diseases, such as atopic keratoconjunctivitis and vernal keratoconjunctivitis, cause severe allergic inflammation in the conjunctiva and corneal epithelial damage, resulting in visual disturbances. The involvement of damage (danger)-associated molecular patterns (DAMPs\/alarmins) in the pathogenesis of these diseases has been recognized. Alarmins released from damaged corneal epithelial cells or eosinophils play a critical role in the induction of corneal lesions, vicious loop of corneal injury, and exacerbation of conjunctival allergic inflammation. Alarmins in the conjunctiva also play an essential role in the development of both allergic inflammation, based on the acquired immune system, and type 2 inflammation by innate immune responses in the ocular surface. Therefore, alarmins may be a potentially important therapeutic target in severe refractory ocular allergic diseases.<\/jats:p>","DOI":"10.3390\/cells11061051","type":"journal-article","created":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T21:25:00Z","timestamp":1647811500000},"page":"1051","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Role of Damage-Associated Molecular Patterns (DAMPs\/Alarmins) in Severe Ocular Allergic Diseases"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4990-6308","authenticated-orcid":false,"given":"Ken","family":"Fukuda","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Kochi Medical School, Kochi University, Kochi 783-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3217-3059","authenticated-orcid":false,"given":"Waka","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Kochi Medical School, Kochi University, Kochi 783-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5437-7298","authenticated-orcid":false,"given":"Tatsuma","family":"Kishimoto","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Kochi Medical School, Kochi University, Kochi 783-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isana","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Kochi Medical School, Kochi University, Kochi 783-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusaku","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Kochi Medical School, Kochi University, Kochi 783-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamaki","family":"Sumi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Kochi Medical School, Kochi University, Kochi 783-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9354-8558","authenticated-orcid":false,"given":"Kenji","family":"Yamashiro","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Kochi Medical School, Kochi University, Kochi 783-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2015.03.048","article-title":"The allergy epidemics: 1870\u20132010","volume":"136","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.alit.2020.06.004","article-title":"Epidemiological aspects of allergic conjunctivitis","volume":"69","author":"Miyazaki","year":"2020","journal-title":"Allergol. Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2332\/allergolint.54.51","article-title":"Treatment of corneal lesions in individuals with vernal keratoconjunctivitis","volume":"54","author":"Kumagai","year":"2005","journal-title":"Allergol. Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.alit.2020.03.005","article-title":"Japanese guidelines for allergic conjunctival diseases 2020","volume":"69","author":"Miyazaki","year":"2020","journal-title":"Allergol. Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2745.2003.01616.x","article-title":"Vernal keratoconjunctivitis: Evidence for immunoglobulin E-dependent and immunoglobulin E-independent eosinophilia","volume":"33","author":"Ono","year":"2003","journal-title":"Clin. Exp. Allergy"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2332\/allergolint.55.121","article-title":"Fibroblasts as local immune modulators in ocular allergic disease","volume":"55","author":"Fukuda","year":"2006","journal-title":"Allergol. Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"108229","DOI":"10.1016\/j.exer.2020.108229","article-title":"Corneal fibroblasts: Function and markers","volume":"200","author":"Fukuda","year":"2020","journal-title":"Exp. Eye Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.preteyeres.2005.09.002","article-title":"Role of structural cells of the cornea and conjunctiva in the pathogenesis of vernal keratoconjunctivitis","volume":"25","author":"Kumagai","year":"2006","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/all.14318","article-title":"Type 2 immunity in the skin and lungs","volume":"75","author":"Akdis","year":"2020","journal-title":"Allergy"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1097\/ICO.0000000000002548","article-title":"Roles of Type 2 Immune Response-Initiating Cytokines and Detection of Type 2 Innate Lymphoid Cells in Mouse Models of Allergic Conjunctivitis","volume":"39","author":"Asada","year":"2020","journal-title":"Cornea"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1167\/iovs.15-16563","article-title":"Roles of Epithelial Cell-Derived Type 2-Initiating Cytokines in Experimental Allergic Conjunctivitis","volume":"56","author":"Asada","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1167\/iovs.08-3365","article-title":"The role of interleukin-33 in chronic allergic conjunctivitis","volume":"50","author":"Matsuda","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/08820538.2016.1238097","article-title":"Clinical Severity and Tear Biomarkers, Eosinophil Cationic Protein and CCL23, in Chronic Allergic Conjunctival Diseases","volume":"33","author":"Shoji","year":"2018","journal-title":"Semin. Ophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/09273949509057807","article-title":"The role of eosinophil cationic protein (ECP) and histamine in vernal keratoconjunctivitis","volume":"3","author":"Secchi","year":"1995","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2222.2003.01538.x","article-title":"Atopy and serum eosinophil cationic protein in 110 white children with vernal keratoconjunctivitis: Differences between tarsal and limbal forms","volume":"33","author":"Pucci","year":"2003","journal-title":"Clin. Exp. Allergy"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0002-9394(14)71463-1","article-title":"Eosinophil granule major basic protein deposition in corneal ulcers associated with vernal keratoconjunctivitis","volume":"115","author":"Trocme","year":"1993","journal-title":"Am. J. Ophthalmol."},{"key":"ref_17","first-page":"3051","article-title":"Eosinophil granule major basic protein inhibition of corneal epithelial wound healing","volume":"35","author":"Trocme","year":"1994","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0091-6749(99)70206-X","article-title":"Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage","volume":"103","author":"Fukagawa","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000024310","article-title":"IL-4 induces eotaxin production in corneal keratocytes but not in epithelial cells","volume":"121","author":"Fukagawa","year":"2000","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_20","first-page":"1448","article-title":"Synergistic induction of eotaxin expression in human keratocytes by TNF-\u03b1 and IL-4 or IL-13","volume":"41","author":"Kumagai","year":"2000","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1167\/iovs.09-4161","article-title":"Inhibition by tranilast of the cytokine-induced expression of chemokines and the adhesion molecule VCAM-1 in human corneal fibroblasts","volume":"51","author":"Adachi","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00003226-200308000-00014","article-title":"Synergistic effect of TNF-\u03b1 and either IL-4 or IL-13 on VCAM-1 expression by cultured human corneal fibroblasts","volume":"22","author":"Kumagai","year":"2003","journal-title":"Cornea"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1067\/mai.2003.59","article-title":"Differential expression of thymus- and activation-regulated chemokine (CCL17) and macrophage-derived chemokine (CCL22) by human fibroblasts from cornea, skin, and lung","volume":"111","author":"Fukuda","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/bbrc.2000.3890","article-title":"Synergistic effect of TNF-\u03b1 and IL-4 on the expression of thymus- and activation-regulated chemokine in human corneal fibroblasts","volume":"279","author":"Kumagai","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.coi.2005.06.002","article-title":"Alarmins: Chemotactic activators of immune responses","volume":"17","author":"Oppenheim","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/sj.embor.7400759","article-title":"Alarmin(g) news about danger: Workshop on innate danger signals and HMGB1","volume":"7","author":"Harris","year":"2006","journal-title":"EMBO Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/jid.2012.66","article-title":"IL-33: A novel danger signal system in atopic dermatitis","volume":"132","author":"Cevikbas","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nm.2731","article-title":"Innate and adaptive immune responses in asthma","volume":"18","author":"Holgate","year":"2012","journal-title":"Nat. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1600-065X.2011.01025.x","article-title":"Innate immunity in allergic disease","volume":"242","author":"Minnicozzi","year":"2011","journal-title":"Immunol. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"8549","DOI":"10.1167\/iovs.11-7956","article-title":"Role of the IL-6 classic- and trans-signaling pathways in corneal sterile inflammation and wound healing","volume":"52","author":"Ebihara","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10384-017-0528-7","article-title":"Cytokine expression and barrier disruption in human corneal epithelial cells induced by alarmin released from necrotic cells","volume":"61","author":"Fukuda","year":"2017","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1167\/iovs.13-11969","article-title":"Alarmins from corneal epithelial cells upregulate CCL11 and VCAM-1 in corneal fibroblasts","volume":"54","author":"Fukuda","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0002-9394(99)00295-0","article-title":"Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases","volume":"129","author":"Leonardi","year":"2000","journal-title":"Am. J. Ophthalmol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1398-9995.1997.tb04810.x","article-title":"The eosinophil and the eye","volume":"52","author":"Bonini","year":"1997","journal-title":"Allergy"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.4049\/jimmunol.123.6.2925","article-title":"Cytotoxic properties of the eosinophil major basic protein","volume":"123","author":"Gleich","year":"1979","journal-title":"J. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1164\/ajrccm\/139.3.801","article-title":"Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro","volume":"139","author":"Motojima","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_37","first-page":"593","article-title":"Effects of eosinophil granule proteins on human corneal epithelial cell viability and morphology","volume":"38","author":"Trocme","year":"1997","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1084\/jem.20062027","article-title":"Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses","volume":"205","author":"Yang","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1167\/iovs.04-1077","article-title":"Activation of toll-like receptor (TLR)2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation","volume":"46","author":"Johnson","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/bjo.2005.082289","article-title":"Expression of CRAMP via PGN-TLR-2 and of alpha-defensin-3 via CpG-ODN-TLR-9 in corneal fibroblasts","volume":"90","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2332\/allergolint.10-OA-0247","article-title":"Synergistic induction of eotaxin and VCAM-1 expression in human corneal fibroblasts by staphylococcal peptidoglycan and either IL-4 or IL-13","volume":"60","author":"Fukuda","year":"2011","journal-title":"Allergol. Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3928\/1081597X-20080201-05","article-title":"Mechanical corneal epithelium scraping and ethanol treatment up-regulate cytokine gene expression differently in rabbit cornea","volume":"24","author":"Chang","year":"2008","journal-title":"J. Refract. Surg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.exer.2008.02.001","article-title":"Topical interleukin-1 receptor antagonist inhibits inflammatory cell infiltration into the cornea","volume":"86","author":"Stapleton","year":"2008","journal-title":"Exp. Eye Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"493.e2","DOI":"10.1016\/j.jaci.2009.10.041","article-title":"Reciprocal interaction of the conjunctiva and cornea in ocular allergy","volume":"125","author":"Fukuda","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1097\/ICO.0b013e3181ea9b2b","article-title":"Ocular allergic inflammation: Interaction between the cornea and conjunctiva","volume":"29","author":"Fukuda","year":"2010","journal-title":"Cornea"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.4049\/jimmunol.1003383","article-title":"Mast cells as sensors of cell injury through IL-33 recognition","volume":"186","author":"Enoksson","year":"2011","journal-title":"J. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jtos.2020.06.006","article-title":"Epithelium-derived IL-33 activates mast cells to initiate neutrophil recruitment following corneal injury","volume":"18","author":"Elbasiony","year":"2020","journal-title":"Ocul. Surf."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1167\/iovs.17-23398","article-title":"Mast Cells Initiate the Recruitment of Neutrophils Following Ocular Surface Injury","volume":"59","author":"Sahu","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/intimm\/dxq035","article-title":"Contribution of IL-33 to induction and augmentation of experimental allergic conjunctivitis","volume":"22","author":"Yoshimoto","year":"2010","journal-title":"Int. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/09273948.2016.1184285","article-title":"Inhibition by tranilast of the synergistic induction of degranulation and IL-13 expression by IL-33 and Fc\u03b5RI cross-linking in mast cells","volume":"25","author":"Tsuji","year":"2017","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/iid3.189","article-title":"Contributions of Interleukin-33 and TSLP in a papain-soaked contact lens-induced mouse conjunctival inflammation model","volume":"5","author":"Sugita","year":"2017","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"36150","DOI":"10.1038\/srep36150","article-title":"Pollen\/TLR4 Innate Immunity Signaling Initiates IL-33\/ST2\/Th2 Pathways in Allergic Inflammation","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"10053","DOI":"10.1038\/s41598-017-10227-y","article-title":"Expression of IL-33 in ocular surface epithelium induces atopic keratoconjunctivitis with activation of group 2 innate lymphoid cells in mice","volume":"7","author":"Imai","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1167\/iovs.09-4122","article-title":"TSLP and downstream molecules in experimental mouse allergic conjunctivitis","volume":"51","author":"Zheng","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1318.e2","DOI":"10.1016\/j.jaci.2011.06.041","article-title":"Short ragweed pollen triggers allergic inflammation through Toll-like receptor 4-dependent thymic stromal lymphopoietin\/OX40 ligand\/OX40 signaling pathways","volume":"128","author":"Li","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/02713683.2021.1874022","article-title":"IL-1\u03b1 antibody inhibits dose-dependent exacerbation of eosinophilic inflammation by crude house-dust-mite antigen in the conjunctiva of an atopic keratoconjunctivitis mouse model","volume":"46","author":"Shiraki","year":"2021","journal-title":"Curr. Eye Res."},{"key":"ref_57","first-page":"3041","article-title":"Prevention of allergic eye disease by treatment with IL-1 receptor antagonist","volume":"40","author":"Miyazaki","year":"1999","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/ICO.0000000000001904","article-title":"Evaluation of Chemokine mRNA Expression to Assess Allergic Inflammation of the Ocular Surface in Chronic Allergic Conjunctival Diseases","volume":"38","author":"Aso","year":"2019","journal-title":"Cornea"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/exer.1998.0499","article-title":"Procollagens and inflammatory cytokine concentrations in tarsal and limbal vernal keratoconjunctivitis","volume":"67","author":"Leonardi","year":"1998","journal-title":"Exp. Eye Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/ijo.IJO_405_17","article-title":"Correlation of interleukin-33 with Th cytokines and clinical severity of dry eye disease","volume":"66","author":"Luo","year":"2018","journal-title":"Indian J. Ophthalmol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1167\/iovs.09-4183","article-title":"Functional role of thymic stromal lymphopoietin in chronic allergic keratoconjunctivitis","volume":"51","author":"Matsuda","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/ICO.0000000000001832","article-title":"Thymic Stromal Lymphopoietin-Related Allergic Pathway in Patients with Vernal Keratoconjunctivitis","volume":"38","author":"Zhang","year":"2019","journal-title":"Cornea"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"5072781","DOI":"10.1155\/2016\/5072781","article-title":"Expression of TSLP and Downstream Molecules IL-4, IL-5, and IL-13 on the Eye Surface of Patients with Various Types of Allergic Conjunctivitis","volume":"2016","author":"Zheng","year":"2016","journal-title":"J. Ophthalmol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1080\/09273948.2018.1467465","article-title":"Increased Lacrimal Fluid Level of HMGB1 in Vernal Keratoconjunctivitis","volume":"27","author":"Caputo","year":"2019","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/pai.12142","article-title":"High-mobility group box-1 (HMGB-1) and serum soluble receptor for advanced glycation end products (sRAGE) in children affected by vernal keratoconjunctivitis","volume":"25","author":"Zicari","year":"2014","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jaip.2020.11.034","article-title":"Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect","volume":"9","author":"Ratchataswan","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.iac.2020.06.008","article-title":"Biologics and Allergy Immunotherapy in the Treatment of Allergic Diseases","volume":"40","author":"Cox","year":"2020","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jaip.2019.10.011","article-title":"Amelioration of conjunctival giant papillae by dupilumab in patients with atopic keratoconjunctivitis","volume":"8","author":"Fukuda","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI124606","article-title":"Epithelial cell-derived cytokines: More than just signaling the alarm","volume":"129","author":"Roan","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2000260","DOI":"10.1183\/13993003.00260-2020","article-title":"Anti-alarmins in asthma: Targeting the airway epithelium with next-generation biologics","volume":"56","author":"Porsbjerg","year":"2020","journal-title":"Eur. Respir. J."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/6\/1051\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:39:48Z","timestamp":1760135988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/6\/1051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,20]]},"references-count":70,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["cells11061051"],"URL":"https:\/\/doi.org\/10.3390\/cells11061051","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,20]]}}}